Mild Clostridium difficile infection (CDI; stool frequency <four ... and place on therapy immediately if this occurs. Treatment for an initial episode and a first recurrence of CDI: If oral ...

The Clostridioides difficile Infections (Clostridium difficile Associated Disease) drugs in development market research report provides comprehensive information on the therapeutics under development ...

Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.

At this stage, the white cell count may be very high. This is an indicator of worsening infection. By this stage, the infected individual should be seeking medical treatment. More than 10 watery ...

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Benjamin Colwell [Opens in a new window], ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

In the U.S. there are almost half a million infections each year and approximately 30,000 deaths. Dr. Thomas Louie of University of Calgary, Canada, principal investigator for this study, stated: ...